Contact
Please use this form to send email to PR contact of this press release:
NABRIVA Receives European Approval for XENLETA® (lefamulin) for Treatment of Community-Acquired Pneumonia (CAP)
TO:
Please use this form to send email to PR contact of this press release:
NABRIVA Receives European Approval for XENLETA® (lefamulin) for Treatment of Community-Acquired Pneumonia (CAP)
TO: